Clinical Trial Update: A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing weekly Insulin icodec with daily Insulin glargine, both given with Insulin aspart, in adults with Type 1 diabetes; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• Insulin Icodec (insulin icodec)
• Insulin aspart (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: RECRUITING